This announcement is a separate document:
百诚医药：关于调整公司2022年限制性股票激励计划授予价格的公告
Baicheng Pharmaceutical: Announcement on Adjusting the Price Granted by the Company\'s 2022 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.